Molecular Partners Ag (MOLN) Total Current Liabilities (2020 - 2026)

Molecular Partners Ag (MOLN) has reported Total Current Liabilities for 7 consecutive years, with $11236.4 the latest figure, recorded in Q1 2026.

• Quarterly Total Current Liabilities rose 12.69% year-over-year to $11236.4 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11236.4 (up 12.69% YoY) and the FY2025 annual result came in at $13796.6, down 99.89% from the prior year.
• Total Current Liabilities declined to $11236.4 in Q1 2026 per MOLN's latest filing, from $13796.6 in the prior quarter.
• Over the last five years, Total Current Liabilities for MOLN reached as high as $24.2 million in Q2 2022 and fell as low as $9971.3 in Q1 2025.
• A 5-year average of $5.9 million and a median of $16626.1 in 2023 frame the typical range for Total Current Liabilities.
• The largest YoY upside for Total Current Liabilities was 21.87% in 2025 against a maximum downside of 99.89% in 2025.
• Year by year, Total Current Liabilities stood at $17.9 million in 2022, then retreated by 9.24% to $16.3 million in 2023, then decreased by 24.25% to $12.3 million in 2024, then plunged by 99.89% to $13796.6 in 2025, then retreated by 18.56% to $11236.4 in 2026.
• According to Business Quant data, Total Current Liabilities over the past three periods registered $11236.4, $13796.6, and $14678.8 for Q1 2026, Q4 2025, and Q3 2025 respectively.